P3.08F.01 Interim Analysis of a Phase 2 Prospective Trial of Induction Lorlatinib in Locally Advanced ALK-Positive NSCLC (LORIN)
Author:
W.-Z. Zhong,C. Zhang,Y. Yang,J. Yang,Q. Zhou,Q. Zhong,W. Liang,Z. Chen,Y. Wu
Publication:
Journal of Thoracic Oncology
Copyright © 2024 Published by Elsevier Inc.